HutchMED (China) LIMITED Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
HutchMED (China) LIMITED (HMDCF) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of $5.15 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2026-03-05
- HutchMED (China) LIMITED effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2019-12-31 was $2.13M, a 251.15% increase year-over-year.
- HutchMED (China) LIMITED effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2019-09-30 was $869.00K, a 43.87% increase year-over-year.
- HutchMED (China) LIMITED effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2019-06-30 was $399.00K, a 19.39% decline year-over-year.
- HutchMED (China) LIMITED effective income tax rate reconciliation, nondeductible expense, amount for the quarter ending 2019-03-31 was $695.00K, a 256.41% increase year-over-year.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 3 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 6 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 9 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|---|---|---|
| 2025-06-30 | $5.15M 6-K · filed 2025-08-07 | |||
| 2024-12-31 | $10.13M 20-F · filed 2026-03-05 | |||
| 2024-06-30 | $7.55M 6-K · filed 2025-08-07 | |||
| 2023-12-31 | $7.09M 20-F · filed 2026-03-05 | |||
| 2023-06-30 | $2.83M 6-K · filed 2024-07-31 | |||
| 2022-12-31 | $8.89M 20-F · filed 2025-03-19 | |||
| 2022-06-30 | $3.07M 6-K · filed 2023-07-31 | |||
| 2021-12-31 | $8.68M 20-F · filed 2024-02-28 | |||
| 2021-06-30 | $3.03M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | $3.48M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | $1.62M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | $2.13M derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | $3.00M derived: sum of 2 quarters · filed 2022-03-03 | $3.40M derived: sum of 3 quarters · filed 2022-03-03 | $4.10M 20-F · filed 2022-03-03 |
| 2019-09-30 | $869.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $1.27M derived: sum of 2 quarters · filed 2020-07-30 | $1.96M 6-K · filed 2020-01-21 | $2.57M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $399.00K derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $1.09M 6-K · filed 2020-07-30 | $1.70M derived: sum of 3 quarters · filed 2021-03-04 | $2.31M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $695.00K 6-K · filed 2019-06-06 | $1.30M derived: sum of 2 quarters · filed 2021-03-04 | $1.91M derived: sum of 3 quarters · filed 2021-03-04 | $2.40M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $608.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | $1.21M derived: sum of 2 quarters · filed 2021-03-04 | $1.71M derived: sum of 3 quarters · filed 2021-03-04 | $1.90M 20-F · filed 2021-03-04 |
| 2018-09-30 | $604.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $1.10M derived: sum of 2 quarters · filed 2020-01-21 | $1.29M 6-K · filed 2020-01-21 | |
| 2018-06-30 | $495.00K derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | $690.00K 6-K · filed 2019-07-30 | ||
| 2018-03-31 | $195.00K 6-K · filed 2019-06-06 | |||
| 2017-12-31 | $391.00K 20-F · filed 2020-03-03 | |||
| 2017-06-30 | $261.00K 6-K · filed 2018-07-27 | |||
| 2016-12-31 | $688.00K 20-F · filed 2019-03-11 | |||
| 2016-06-30 | $272.00K 6-K · filed 2017-07-31 | |||
| 2015-12-31 | $253.00K 20-F · filed 2018-03-12 | |||
| 2014-12-31 | $399.00K 20-F · filed 2017-03-13 |